6505--Acamprosate CA EC Tablets
Closed Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- 36E79726R0021
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The VA National Acquisition Center is seeking to procure Acamprosate Calcium (CA) Enteric Coated (EC) Tablets through Request for Proposal 36E79726R0021, an unrestricted federal procurement serving the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. Offerors must provide the exact drug name as it appears on the label with a unique NDC number and cannot affix their label over another existing label. Critical packaging specifications include unit-of-use 180-count bottles with a minimum 120cc cylindrical volume, a safety cap convertible to non-safety cap, and accommodation for a 5.25" x 2" label with 0.5 inches of additional exposed space for barcode and product information. The RFP was electronically posted on April 20, 2026, with an anticipated release date of May 7, 2026, and a tentative closing date of May 21, 2026. Questions regarding the solicitation should be directed to Contract Specialist Deb Fassl at Deborah.Fassl@va.gov or 708-786-5894.
This procurement carries no set-aside designation and is open to all responsible offerors capable of providing an uninterrupted source of supply. The estimated annual requirement is 33,661 bottles of 180-count Acamprosate CA EC 333mg tablets, with distribution through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs. The successful contractor will receive a one-year base contract period plus four pre-priced one-year option periods, providing potential contract duration of five years. The solicitation will be issued in commercial item format in accordance with FAR Part 12, with all supporting documents available on SAM.gov. Award will be made to a single responsible offeror selected based on their ability to meet the government's supply requirements and specified packaging and labeling requirements.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79726R0021 for an unrestricted procurement for Acamprosate Calcium (CA) Enteric Coated (EC) Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).
VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DoD s respective Pharmaceutical Prime Vendor Programs.
Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere over the successful offeror/contractor's label.
This product requires unit of use packaging, as identified in the Schedule of Supplies (Line item 1, 180-count bottles). The bottles shall contain a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.
Solicitation #36E79726R0021 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about May 7, 2026, with a tentative closing date of May 21, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at SAM.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Deb Fassl. Questions can be e-mailed to Deborah.Fassl@va.gov.
The estimated annual requirements are as follows:
REQUIREMENT DESCRIPTION
ITEM
DESCRIPTION
UNIT
of
USE
PKG. SIZE
(Tablets
per Bottle)
TOTAL EST. ANNUAL USAGE
(Bottles)
1
ACAMPROSATE CA EC 333MG TAB
Y
180
33,661
Files
| File | Type | Posted |
|---|---|---|
| 36E79726R0021_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Acamprosate CA EC Tablets | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity